Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Tew

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Cancer Immunology, Immunotherapy : CII|July 2, 2022
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combinationRyan M Kahn, Govind Ragupathi, Qin C Zhou, et al.
Journal of Geriatric Oncology|September 11, 2019
The association between social support and chemotherapy-related toxicity in older patients with cancerArmin Shahrokni, Can-Lan Sun, William P Tew, et al.
Gynecologic Oncology|May 13, 2019
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer centerOlga T Filippova, Dennis S Chi, Kara Long Roche, et al.
Gynecologic Oncology|June 6, 2021
Non-exenterative surgical management of recurrent endometrial carcinomaLea A Moukarzel, Kenya F Braxton, Quin C Zhou, et al.
Journal of the American Geriatrics Society|July 22, 2014
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatmentRonald J Maggiore, William Dale, Cary P Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I studyJason A Konner, Katherine M Bell-McGuinn, Paul Sabbatini, et al.
Cancer|February 24, 2012
Use of complementary medications among older adults with cancerRonald J Maggiore, Cary P Gross, Kayo Togawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancerJason A Konner, Diana M Grabon, Scott R Gerst, et al.
Psycho-Oncology|August 8, 2014
The relationship between age, anxiety, and depression in older adults with cancerTalia R Weiss Wiesel, Christian J Nelson, William P Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancerThomas Boerner, Clarissa Lam, Derman Basaran, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|July 2, 2022
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combinationRyan M Kahn, Govind Ragupathi, Qin C Zhou, et al.
Journal of Geriatric Oncology|September 11, 2019
The association between social support and chemotherapy-related toxicity in older patients with cancerArmin Shahrokni, Can-Lan Sun, William P Tew, et al.
Gynecologic Oncology|May 13, 2019
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer centerOlga T Filippova, Dennis S Chi, Kara Long Roche, et al.
Gynecologic Oncology|June 6, 2021
Non-exenterative surgical management of recurrent endometrial carcinomaLea A Moukarzel, Kenya F Braxton, Quin C Zhou, et al.
Journal of the American Geriatrics Society|July 22, 2014
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatmentRonald J Maggiore, William Dale, Cary P Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2010
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I studyJason A Konner, Katherine M Bell-McGuinn, Paul Sabbatini, et al.
Cancer|February 24, 2012
Use of complementary medications among older adults with cancerRonald J Maggiore, Cary P Gross, Kayo Togawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancerJason A Konner, Diana M Grabon, Scott R Gerst, et al.
Psycho-Oncology|August 8, 2014
The relationship between age, anxiety, and depression in older adults with cancerTalia R Weiss Wiesel, Christian J Nelson, William P Tew, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancerThomas Boerner, Clarissa Lam, Derman Basaran, et al.
Pageof 12